Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rayzebio, Inc. (RYZB) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rayzebio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1825367.
Total stock buying since 2023: $83,500,002.
Total stock sales since 2023: $0.
Total stock option exercises since 2023: $100,035.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 0 | $0 | 30,875 | $100,035 |
| 2023 | 4,638,889 | $83,500,002 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 0 | $0 | 0 | $0 | 30,875 | $100,035 |
| 2023-09 | 4,638,889 | $83,500,002 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-22 | Moran Susan (CHIEF MEDICAL OFFICER) | Option Ex | 30,875 | 3.24 | 100,035 |
| 2023-09-19 | Katabi Maha (Director) | Buy | 472,222 | 18.00 | 8,499,996 |
| 2023-09-19 | Shabet Rose Sharon | Buy | 2,777,778 | 18.00 | 50,000,004 |
Insider trading activities including stock purchases, stock sales, and option exercises of RYZB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rayzebio, Inc. (symbol RYZB, CIK number 1825367) see the Securities and Exchange Commission (SEC) website.